BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23999043)

  • 1. Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes.
    Freskos JN; Asmelash B; Gaston KR; Karwa A; Marzan TA; Nickols MA; Rogers TE; Schoenstein T; Sympson CJ; Vu B
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5566-70. PubMed ID: 23999043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases.
    Faust A; Waschkau B; Waldeck J; Höltke C; Breyholz HJ; Wagner S; Kopka K; Heindel W; Schäfers M; Bremer C
    Bioconjug Chem; 2008 May; 19(5):1001-8. PubMed ID: 18396900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.
    Fabre B; Filipiak K; Díaz N; Zapico JM; Suárez D; Ramos A; de Pascual-Teresa B
    Chembiochem; 2014 Feb; 15(3):399-412. PubMed ID: 24449516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
    Tauro M; Laghezza A; Loiodice F; Agamennone M; Campestre C; Tortorella P
    Bioorg Med Chem; 2013 Nov; 21(21):6456-65. PubMed ID: 24071448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.
    Nanjan P; Nambiar J; Nair BG; Banerji A
    Bioorg Med Chem; 2015 Jul; 23(13):3781-7. PubMed ID: 25907368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.
    Nuti E; Cantelmo AR; Gallo C; Bruno A; Bassani B; Camodeca C; Tuccinardi T; Vera L; Orlandini E; Nencetti S; Stura EA; Martinelli A; Dive V; Albini A; Rossello A
    J Med Chem; 2015 Sep; 58(18):7224-40. PubMed ID: 26263024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.
    Beutel B; Daniliuc CG; Riemann B; Schäfers M; Haufe G
    Bioorg Med Chem; 2016 Feb; 24(4):902-9. PubMed ID: 26810711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.
    Cheng XC; Wang RL; Dong ZK; Li J; Li YY; Li RR
    Bioorg Med Chem; 2012 Oct; 20(19):5738-44. PubMed ID: 22967811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.
    Zhang J; Li X; Jiang Y; Feng J; Li X; Zhang Y; Xu W
    Bioorg Med Chem; 2014 Jun; 22(11):3055-64. PubMed ID: 24755524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carborane-Containing Matrix Metalloprotease (MMP) Ligands as Candidates for Boron Neutron-Capture Therapy (BNCT).
    Lutz MR; Flieger S; Colorina A; Wozny J; Hosmane NS; Becker DP
    ChemMedChem; 2020 Oct; 15(20):1897-1908. PubMed ID: 32720425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New in Vivo Compatible Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitors.
    Beutel B; Song J; Konken CP; Korpos E; Schinor B; Gerwien H; Vidyadharan R; Burmeister M; Li L; Haufe G; Sorokin L
    Bioconjug Chem; 2018 Nov; 29(11):3715-3725. PubMed ID: 30277751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms.
    Bellini T; Trentini A; Manfrinato MC; Tamborino C; Volta CA; Di Foggia V; Fainardi E; Dallocchio F; Castellazzi M
    J Biochem; 2012 May; 151(5):493-9. PubMed ID: 22343748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.
    Selivanova SV; Stellfeld T; Heinrich TK; Müller A; Krämer SD; Schubiger PA; Schibli R; Ametamey SM; Vos B; Meding J; Bauser M; Hütter J; Dinkelborg LM
    J Med Chem; 2013 Jun; 56(12):4912-20. PubMed ID: 23688254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
    Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.
    Adhikari N; Halder AK; Mallick S; Saha A; Saha KD; Jha T
    Bioorg Med Chem; 2016 Sep; 24(18):4291-4309. PubMed ID: 27452283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphenyl substituted lysine derivatives as recognition elements for the matrix metalloproteinases MMP-2 and MMP-9.
    Kirchhain A; Zubrienė A; Kairys V; Vivaldi F; Bonini A; Biagini D; Santalucia D; Matulis D; Di Francesco F
    Bioorg Chem; 2021 Oct; 115():105155. PubMed ID: 34303036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 Inhibitors.
    Wang PF; Qiu HY; Baloch SK; Gong HB; Wang ZC; Zhu HL
    Chem Biol Drug Des; 2015 Dec; 86(6):1405-10. PubMed ID: 26061284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of matrix metalloproteinase inhibitors by chemical arrays.
    Kawatani M; Fukushima Y; Kondoh Y; Honda K; Sekine T; Yamaguchi Y; Taniguchi N; Osada H
    Biosci Biotechnol Biochem; 2015; 79(10):1597-602. PubMed ID: 25988721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of matrix metalloproteinases 2 and 9 in corneal neovascularization.
    Zhang J; Wang S; He Y; Yao B; Zhang Y
    Chem Biol Drug Des; 2020 May; 95(5):485-492. PubMed ID: 31002472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and preliminary bioactivity evaluations of 8-hydroxyquinoline derivatives as matrix metalloproteinase (MMP) inhibitors.
    Chen C; Yang X; Fang H; Hou X
    Eur J Med Chem; 2019 Nov; 181():111563. PubMed ID: 31415980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.